(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 25 879.00 |
Vidutinė apimtis | 19 952.00 |
Rinkos kapitalizacija | 695.20M |
EPS | $0 ( 2024-02-26 ) |
Kita pelno data | ( $0 ) 2024-05-06 |
Last Dividend | $2.20 ( 2023-11-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 35.78 |
ATR14 | $3.46 (0.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-08 | Ferguson Cindy | Sell | 163 | restricted stock units |
2024-03-08 | Ferguson Cindy | Buy | 163 | common stock |
2024-03-08 | Ferguson Cindy | Sell | 45 | common stock |
2024-01-02 | Stupp John P Jr | Buy | 10 | stock units |
2024-01-02 | Ferguson Cindy | Buy | 14 | restricted stock units |
INSIDER POWER |
---|
-4.62 |
Last 93 transactions |
Buy: 23 820 | Sell: 40 633 |
Atrion Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
NTGR | 0.882 |
WMG | 0.879 |
BOWX | 0.877 |
TUEM | 0.871 |
DMTK | 0.867 |
ZD | 0.864 |
SBAC | 0.861 |
GDS | 0.861 |
MRNA | 0.856 |
COLM | 0.856 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
FRHC | -0.869 |
MTRY | -0.861 |
KSICU | -0.859 |
AVDL | -0.859 |
MORF | -0.859 |
COKE | -0.859 |
DKNG | -0.854 |
OTTR | -0.844 |
NBSTU | -0.842 |
PTOC | -0.839 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Atrion Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $169.33M |
Bruto pelnas: | $62.39M (36.84 %) |
EPS: | $11.02 |
FY | 2023 |
Pajamos: | $169.33M |
Bruto pelnas: | $62.39M (36.84 %) |
EPS: | $11.02 |
FY | 2022 |
Pajamos: | $183.51M |
Bruto pelnas: | $75.90M (41.36 %) |
EPS: | $19.59 |
FY | 2021 |
Pajamos: | $165.01M |
Bruto pelnas: | $69.37M (42.04 %) |
EPS: | $18.00 |
Financial Reports:
No articles found.
Atrion Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.15 (N/A) |
$2.20 (N/A) |
$2.20 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.183 | 1990-02-12 |
Last Dividend | $2.20 | 2023-11-30 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 117 | -- |
Total Paid Out | $94.61 | -- |
Avg. Dividend % Per Year | 0.85% | -- |
Score | 4.71 | -- |
Div. Sustainability Score | 9.69 | |
Div.Growth Potential Score | 2.80 | |
Div. Directional Score | 6.24 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0.732 | 9.87% |
1991 | $0.732 | 7.71% |
1992 | $0.783 | 7.12% |
1993 | $0.800 | 5.27% |
1994 | $0.800 | 5.78% |
1995 | $0.800 | 7.27% |
1996 | $0.800 | 5.60% |
1997 | $0.600 | 3.87% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0.240 | 1.07% |
2004 | $0.520 | 1.14% |
2005 | $0.620 | 1.33% |
2006 | $0.740 | 1.09% |
2007 | $0.880 | 1.12% |
2008 | $1.080 | 0.87% |
2009 | $1.320 | 1.36% |
2010 | $10.56 | 6.78% |
2011 | $1.820 | 0.97% |
2012 | $12.10 | 5.03% |
2013 | $2.40 | 1.19% |
2014 | $2.78 | 0.96% |
2015 | $3.30 | 0.97% |
2016 | $3.90 | 1.04% |
2017 | $4.50 | 0.90% |
2018 | $5.10 | 0.82% |
2019 | $5.80 | 0.79% |
2020 | $6.60 | 0.89% |
2021 | $7.40 | 1.13% |
2022 | $8.20 | 1.17% |
2023 | $8.70 | 1.53% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.115 | 1.500 | 7.71 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0744 | 1.200 | 7.52 | 9.02 | [0 - 0.3] |
returnOnEquityTTM | 0.0807 | 1.500 | -0.215 | -0.322 | [0.1 - 1] |
payoutRatioTTM | 0.789 | -1.000 | 2.11 | -2.11 | [0 - 1] |
currentRatioTTM | 9.09 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.32 | 0.800 | 1.057 | 0.845 | [0.8 - 2.5] |
cashRatioTTM | 0.282 | 1.500 | 9.54 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.000920 | -1.500 | 9.98 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -9.13 | 1.000 | -4.49 | -4.49 | [3 - 30] |
operatingCashFlowPerShareTTM | 11.37 | 2.00 | 6.21 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -1.314 | 2.00 | -0.657 | -1.314 | [0 - 20] |
debtEquityRatioTTM | 0.000988 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.368 | 1.000 | 7.19 | 7.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.117 | 1.000 | 9.66 | 9.66 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 83.36 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.649 | 0.800 | 9.01 | 7.20 | [0.5 - 2] |
Total Score | 9.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 35.82 | 1.000 | 6.48 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0807 | 2.50 | -0.138 | -0.322 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.314 | 2.00 | -0.438 | -1.314 | [0 - 30] |
dividendYielPercentageTTM | 2.22 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 11.37 | 2.00 | 6.21 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.789 | 1.500 | 2.11 | -2.11 | [0 - 1] |
pegRatioTTM | -10.20 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.118 | 1.000 | 9.55 | 0 | [0.1 - 0.5] |
Total Score | 2.80 |
Atrion Corp
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.